South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission 
Czech-based Mewery has introduced a prototype of microalgae-based cultivated meat, combining 75 percent pork cells and 25 percent microalgae cells.
The scientific team of Mewery, a cell-based food tech start-up, , cultivated this prototype in 10 weeks.
According to Mewery founder, Roman Lauš, they already have several variants that work for them without animal products and which they continue to work with.
The addition of microalgae improves the product's nutritional value by providing vitamins, antioxidants, minerals, fiber, and vital fatty acids.
Mewery hopes to have the finished product available for sale in two years. Once the necessary legislation is ready, consumers will have access to it.
